Dynamics of biochemical and immunological blood markers in patients with pseudoarthrosis of the femoral neck after total hip arthroplasty

Keywords: biomarkers, interleukins, glycoproteins, sialic acids, total hip replacement

Abstract

The importance of biomarkers to predict recovery following total hip arthroplasty (THA) is still unclear to clinicians. To assess the preoperative biomarkers of patients with pseudoarthrosis of the femoral neck and their dynamics in the early postoperative period after THA, 50 patients aged 33 to 82 years old, 18 males and 32 females diagnosed with pseudoarthrosis of the femoral neck after failed internal fixation and failed conservative management were studied. The control group consisted of 30 healthy people aged 27 to 50 years, 13 males, 17 females. Patients’ blood was examined for biochemical markers upon admission, and then on the 7th and 14th days after surgery. Their blood serum content of total protein, albumin, glycoproteins, sialic acids, chondroitin sulfates, haptoglobin, glucose, cholesterol, triglycerides, ALT, AST, alkaline phosphatase, GGT, acid phosphatase, thymol index; interleukins (IL-1, IL-4 and IL-6.) and C-reactive protein was measured. The content of glycoproteins in the blood exceeded the norm by 2.3 times, chondroitin sulfate by 4.7 times, sialic acids by 1.5 times, haptoglobin by 55.8%, fibrinogen by 19.1%, globulin by 19,6%, alkaline phosphatase activity by 72.3%, IL-1 by 94.7 and IL-6 by 3 times, C-reactive protein by 2.6 times. After THA there was a gradual decrease in blood biochemical and immunological markers. The most informative laboratory markers were glycoproteins, chondroitin sulfates, sialic acids, haptoglobin, activity of alkaline phosphatase, IL-1, IL-6 and IL-4, and C-reactive protein. Subsequent research is required to validate these dynamics. 

References

Abou-El-Khier, N. T., Ganainy, A.-R., Elgeidy, A., & Rakha, S. A. (2013). Assessment of interleukin-6 and other inflammatory markers in the diagnosis of Egyptian patients with periprosthetic joint infection. Egyptian Journal of Immunology, 20(2), 93–99.

Berbari, E., Mabry, T., Tsaras, G., Spangehl, M., Erwin, P. J., Murad, M. H., Steckelberg, J., & Osmon, D. (2010). Inflammatory blood laboratory levels as markers of prosthetic joint infection: A systematic review and meta-analysis. Journal of Bone and Joint Surgery. 1,92(11), 2102–2109.

Chen, X. X., Wang, T., Li, J., & Kang, H. (2016). Relationship between in flammatory response and estimated complication rate after total hip arthro plasty. Chinese Medical Journal, 129(21), 2546–2551.

Conway, F. J., Talwar, D., & McMillan, D. C. (2015). The relationship between acute changes in the systemic inflammatory response and plasma ascorbic acid, alpha-tocopherol and lipid peroxidation after elective hip arthroplasty. Clinical Nutrition, 34(4), 642–646.

Dargan, D., McCaffrey, D., & Kealey, W. D. C. (2012). Pseudoarthrosis of femoral neck stress fracture treated with open reduction, sliding hip screw and bone morphogenic protein. International Journal of Surgery Case Reports, 3(11), 529–532.

Drago, L., Vassena, C., Dozio, E., Corsi, M. M., De Vecchi, E., Mattina, R., & Romanò, C. (2011). Procalcitonin, C-reactive protein, interleukin-6, and so luble intercellular adhesion molecule-1 as markers of postoperative orthopae dic joint prosthesis infections. International Journal of Immunopathology and Pharmacology, 24(2), 433–340.

Eastwood, S. E., John, A., Jones, S. A., Hodgson, H., Mason, D., Waddington, R., & Wei, X. (2015). Osteoclastogenesis-related cytokines and peri-pros thetic osteolysis in revision metal-on-metal total hip replacements. Hip International, 25(4), 355–360.

Elgeidi, A., Elganainy, A. E., Abou Elkhier, N., & Rakha, S. (2014). Interleu kin-6 and other inflammatory markers in diagnosis of periprosthetic joint infection. International Orthopaedics, 38(12), 2591–2595.

Glehr, M., Friesenbichler, J., Hofmann, G., & Bernhardt, G. A. (2013). Novel biomarkers to detect infection in revision hip and knee arthroplasties. Clinical Orthopaedics and Related Research, 471(8), 2621–2628.

He, T., Wu, W., Huang, Y., Zhang, X., Tang, T., & Dai, K. (2013). Multiple biomarkers analysis for the early detection of prosthetic aseptic loosening of hip arthroplasty. International Orthopaedics, 37(6), 1025–1031.

Hoell, S., Borgers, L., Gosheger, G., Dieckmann, R., Schulz, D., Gerss, J., & Hardes, J. (2015). Interleukin-6 in two-stage revision arthroplasty: What is the threshold value to exclude persistent infection before re-implantation? Bone and Joint Journal, 97B(1), 71–75.

Mei, X. L., Guo, T., & Zhao, J. N. (2011). Clinical significance and expression of the inflammatory cytokines (IL-1, IL-2, IL-6 and IL-10) in blood serum of the patients after total hip replacement. China Journal of Orthopaedics and Traumatology, 24(6), 463–465.

Motaghedi, R., Bae, J. J., Memtsoudis, S. G., & Kim, D. H. (2014). Association of obesity with inflammation and pain after total hip arthroplasty. Clinical Orthopaedics and Related Research, 472(5), 1442–1448.

Musil, D., Stehlík, J., & Verner, M. (2008) A comparison of operative invasi veness in minimally invasive anterоlateral hip replacement (MIS-AL) and standard hip procedure, using biochemical markers. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca, 75(1), 16–20.

Parvizi, J., Fassihi, S. C., & Enayatollahi, M. A. (2016). Diagnosis of peripro sthetic joint infection following hip and knee arthroplasty. Orthopedic Clinics of North America, 47(3), 505–515.

Reikeras, O., Borgen, P., Reseland, J. E., & Lyngstadaas, S. P. (2014). Changes in serum cytokines in response to musculoskeletal surgical trauma. BMC Research Notes, 7, 7.

Rissanen, J. (2013) Markers of bone turnover in preclinical development of drugs for skeletal diseases. Department of Cell Biology and Anatomy, University of Turku Doctoral Programme, Finland, p. 13–14.

Singh, G., Nuechtern, J. V., Meyer, H., Fiedler, G. M., Awiszus, F., Junk-Jantsch, S., Bruegel, M., Pflueger, G., & Lohmann, C. H. (2015). Particle characteri sation and cytokine expression in failed small-diameter metal-on-metal total hip arthroplasties. Journal of Bone and Joint Surgery, 97B(7), 917–923.

Szypuła, J., Cabak, A., Kiljański, M., Boguszewski, D., & Tomaszewski, W. (2016). Comparison of biocompatibility of cemented vs. cementless hip joint endoprostheses based on postoperative evaluation of proinflam matory cytokine levels. Medical Science Monitor, 22, 4830–4835.

Wasko, M. K., Bobecka-Wesołowska, K., Tomasiuk, R., & Kowalczewski, J. (2015). Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty. Clinical Chemistry and Laboratory Medicine, 53(11), 1785–1792.

Yu, D., Yin, Z., Fu, C., & Yu, R. (2014). Impact on red blood cell immunity patterns in postoperative phase following total hip arthroplasty. Central-European Journal of Immunology, 39(3), 377–383.

Published
2017-08-13
How to Cite
Bondarenko, S. E., Akonjom, M., Filipenko, V. A., Morozenko, D. V., Badnaoui, A., & Gliebova, K. V. (2017). Dynamics of biochemical and immunological blood markers in patients with pseudoarthrosis of the femoral neck after total hip arthroplasty. Regulatory Mechanisms in Biosystems, 8(3), 423-426. https://doi.org/10.15421/021765